research_3

Discover the role of IgG antibodies in immune defense, pathogen neutralization, and placental immunity, and learn about IgG subclasses (IgG1–IgG4) and their distinct functions.

Explore ethical questions around antibody production in animals, the 3Rs principle, and how recombinant technology reduces animal use while ensuring high-quality science.

Explore how monoclonal antibodies combat COVID-19 by neutralizing SARS-CoV-2, including therapies like Actemra, challenges from emerging variants and Biointron’s antibody research.

Learn how antibodies enable protein–protein interaction research using immunofluorescence, immunoprecipitation and co-immunoprecipitation to study signaling pathways and complexes.

Antibody‑drug conjugates unite precise targeting with potent payloads. Explore linkers, payload classes, DAR control, and the levers that improve efficacy and safety.

Why antibodies transformed immunotherapy: ADCC and CDC, checkpoint blockade, and T‑cell engagement, plus where combinations are headed against resistant tumors.

How ELISA kits achieve specific, reliable readouts: key components, curve fitting, common pitfalls, and QC practices that keep results trustworthy across studies.

VHH combine small size with big performance—excellent stability, deep tissue access, and easy formatting—making them powerful tools for research and therapy.

Recombinant antibodies deliver speed, consistency, and custom design. Learn how they are engineered, validated, and scaled to out‑perform traditional hybridoma tools.

What an antibody is and why it matters: structure, function, and the roles antibodies play across diagnostics and therapy, explained for fast, confident understanding.

Compare delivery options for antibody‑based therapies—conjugates, nanoparticles, liposomes, and long‑acting platforms—to improve exposure, precision, and patient safety.

Our 2023 year‑end networking and game night gathered scientists, partners, and friends to share results, swap ideas, and celebrate antibody discovery that will fuel the next year.